gem 231
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 1999 (NCT00004864)
Timeline
1990s
- Jan 1, 1999
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- cAMP-dependent protein kinase AINHIBITOR
cAMP-dependent protein kinase A inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gem 231
- gem 231
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00004863 | Phase 1 | Jul 1, 1999 | National Cancer Institute (NCI), Yeshiva University |
| NCT00004864 | Phase 1 | Jul 1, 1999 | National Cancer Institute (NCI), Yeshiva University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Cancer Institute (NCI) | Government | 2 | 0 | 1 | 1999 |
| Yeshiva University | Academic/Hospital | 2 | 2 | 1 | 1999 |
2 organizations
Page 1 / 1